PAX Sleep Study

We all know the feeling of waking up after a particularly bad night’s sleep. We’ve been bleary-eyed, grumpy, groggy, and unprepared for the demands of the day. Quality rest from a good night’s sleep is vital. But one third of Americans are not actually getting enough rest¹. Between 50 and 70 million adults are experiencing trouble sleeping, and it’s having an impact beyond merely feeling tired. The negative effects on health, wellbeing and public safety are myriad, and can lead to increased risk of heart disease, diabetes, dementia, depression, obesity, weakened immune systems², and accidents. PAX has taken its considerable resources and interest in helping our society and engaged in an exhaustive, comprehensive study in hopes of tackling this increasingly common and detrimental issue.

Cannabis has long been touted for its relaxing effects, and more and more adults are turning to it to help with their sleep issues. Despite this growing interest, the data on its efficacy has been mixed. While some tout it as a cure-all, perfect for solving the problem of sleeplessness, others claim it further disrupts the rest cycle. Many disagree about which cannabinoids work best to deliver a restful night of sweet shuteye. As leaders in the cannabis industry, we decided to find out for ourselves, leveraging PAX’s long history of data-driven innovation.

The Sleep Study

Our researchers designed and implemented randomized, crossover, single-blind controlled trials using biometric and validated psychometric instruments over the course of 2 years. Our protocol was reviewed by our Health Advisory Board, a team of external leaders in medicine, cannabinoid science, and behavioral health. We recruited 44 participants with subclinical insomnia, without sleep apnea, mental health, or other risk factors for safety purposes.

PAX also conducted an extensive survey of over 500 participants, focused on both male and female cannabis consumers, to determine their sleep habits and perceptions of good and bad sleep. According to the PAX Sleep Survey, more than half of cannabis consumers already use the plant to help get a better night’s sleep. PAX found that those who utilize cannabis to help with sleep prefer fast-acting, inhalable options like pre-rolls, bongs, and vaporizers, so as to feel the effects and get to sleep more quickly.

Among our key findings:

• Indicas do not deliver better sleep
• CBN is not a key component of restfulness
• Terpenes play a crucial role in efficacy

The Sleep Formulation

PAX took this direction and set out to create a pod with a unique blend of cannabinoids and terpenes, which work together to deliver the nightly peace we're all desperately seeking. We developed myriad formulations to test for efficacy and included a cannabinoid-only control, a benchmark control, and an active placebo control. Each product was tested using a combination of biometric data supported by commercial wearables and validated psychometric instruments for both qualitative and quantitative feedback around factors like sleepiness, sleep quality, anxiety and depression, insomnia, duration and quality of sleep.

We tested multiple blends until we found the right combination that makes sleep deep, rest restorative, and waking hours satisfying.

The resulting, unique formula shows a:

• 44% improvement in falling asleep faster
• 25% improvement over generic indica
• 21% improvement over cannabis sleep products
• 38% reporting an improvement in sleep quality

Closing Thoughts

Our research and dedication to solving sleeplessness has led to the development of sleep by PAX. It is a product unlike any other, crafted after years of delving deep into cannabis science. PAX has built a product portfolio based on the most stringent product quality, toxicology, and safety evaluation standards in the industry. sleep by PAX is the newest addition to our cannabis lineup. We are proud to continually offer products that showcase our love for the plant and are backed by real science.

References:

1. Center for Disease Control and Prevention
2. New York Times

Disclaimers

Based on an in-house study using biometric and validated psychometric instruments. The FDA has not evaluated or approved these statements. This product is not intended to diagnose, treat, cure, or prevent any disease. Use only as directed.